Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0000768,
umls-concept:C0012963,
umls-concept:C0026820,
umls-concept:C0027061,
umls-concept:C0030705,
umls-concept:C0155626,
umls-concept:C0443348,
umls-concept:C0581603,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1522318,
umls-concept:C1704240,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1980023,
umls-concept:C2911692
|
pubmed:issue |
6
|
pubmed:dateCreated |
1991-12-31
|
pubmed:abstractText |
To assess the effects of coronary revascularization on viable but noncontractile myocardium, we examined 21 patients with a documented anterior acute myocardial infarction who had a significant improvement in wall motion abnormality evaluated by two-dimensional echocardiography in the infarct-related artery in response to low-dose dobutamine infusion. All patients had a significant residual stenosis in the infarct-related artery. In response to low-dose dobutamine, there was a marked improvement in contractility in the infarct-related area segments and this was reflected by a decrease in echocardiographic score index from 1.5 +/- 0.15 to 1.09 +/- 0.08 (p = 0.0001). Of these 21 patients, 13 underwent successful revascularization: 10 had percutaneous transluminal coronary angioplasty (PTCA) and three had coronary artery bypass grafts (CABG) (group I). Eight patients received medical therapy only (group II). At 40 +/- 15 days of follow-up, both groups had improvement in their segmental wall motion abnormalities. However, the improvement in group I was greater than that in group II, 1.1 +/- 0.13 and 1.35 +/- 0.1, respectively (p = 0.0002). We conclude that: (1) low-dose dobutamine infusion may identify viable but noncontractile myocardium in patients with acute myocardial infarction and (2) in these patients revascularization causes a greater improvement in left ventricular function over time when compared with a nonrevascularized group.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0002-8703
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
122
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1522-31
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1957746-Aged,
pubmed-meshheading:1957746-Coronary Angiography,
pubmed-meshheading:1957746-Dobutamine,
pubmed-meshheading:1957746-Echocardiography,
pubmed-meshheading:1957746-Electrocardiography,
pubmed-meshheading:1957746-Female,
pubmed-meshheading:1957746-Humans,
pubmed-meshheading:1957746-Infusions, Intravenous,
pubmed-meshheading:1957746-Male,
pubmed-meshheading:1957746-Middle Aged,
pubmed-meshheading:1957746-Myocardial Contraction,
pubmed-meshheading:1957746-Myocardial Infarction,
pubmed-meshheading:1957746-Myocardial Reperfusion,
pubmed-meshheading:1957746-Prognosis,
pubmed-meshheading:1957746-Remission Induction
|
pubmed:year |
1991
|
pubmed:articleTitle |
Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization.
|
pubmed:affiliation |
Heart and Vascular Institute, Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, MI 48202.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|